Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients
NCT02758678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2016-10-19
Summary
Purpose:
Selectins are vascular cell adhesion molecules involved in adhesive interactions of leukocytes and platelets and endothelium within the blood circulation.
Plasma soluble P selectin (sP-selectin), is a one of member of selectin family, an adhesion molecule and component of the membrane of the platelet alpha granulate has been proposed as a one marker of platelet activation. In this study we evaluate of expression of P selectin on platelets of blood between serum samples from lung cancer and healthy individuals.
Conditions
Interventions
- BIOLOGICAL
-
A single 2 ml heparinised peripheral blood sample
A single 2 ml heparinised peripheral blood sample was centrifuges to get serum specimens. Serum separation and Raman spectroscopy analysis:
Sponsors & Collaborators
-
University in Zielona Góra
collaborator OTHER -
Science and Technology Park, Center of Innovation Technologies for Human Health
lead INDUSTRY
Principal Investigators
-
Edyta I Wolny-Rokicka, MD.PhD · Clinicial Hospital in Zielona Góra,Radiotherapy Department ul Zyty 26, Zielona Góra, Poland
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2016-10-31
- Completion
- 2016-10-31
Countries
- Poland
Study Locations
More Related Trials
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma
NCT02951897 ·Status: UNKNOWN ·Phase: NA
-
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer
NCT00213733 ·Status: COMPLETED
-
Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer
NCT02701231 ·Status: UNKNOWN ·Phase: NA
-
LC-NMR Study Biomarkers to Detect Lung Cancer
NCT02024113 ·Status: COMPLETED
-
Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy
NCT06557343 ·Status: RECRUITING
-
Lung Cancer Detection by Measuring Monocyte Activity
NCT02090166 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
NCT02758314 ·Status: UNKNOWN
-
Improving Pulmonary Function Following Radiation Therapy
NCT02843568 ·Status: COMPLETED ·Phase: NA
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
Cutting-edge IMAGING Technologies to Improve the SAFEty and the Sustainability of LUNG Cancer Screening and the Accuracy of Non-invasive Lung Nodules Characterization
NCT06963515 ·Status: NOT_YET_RECRUITING
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Detection of Early Lung Cancer by Serum Protein Expression Profiling
NCT00175578 ·Status: UNKNOWN
-
Mass Spectral Fingerprinting in Lung Cancer
NCT02781857 ·Status: COMPLETED
-
Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma
NCT05072561 ·Status: UNKNOWN ·Phase: NA
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
NCT03721133 ·Status: ENROLLING_BY_INVITATION
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
NCT03791034 ·Status: RECRUITING
-
Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool
NCT02172027 ·Status: WITHDRAWN
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
NCT06775002 ·Status: NOT_YET_RECRUITING
-
Rapid Learning for Lung Cancer
NCT01949259 ·Status: COMPLETED
-
AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer?
NCT06168916 ·Status: COMPLETED